8-K
Genvor Inc (GNVR)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: May 29, 2024
GENVOR
INCORPORATED
(Exact name of Registrant as specified in its Charter)
| Nevada | 000-56589 | 83-2054746 |
|---|---|---|
| (State<br> or Other Jurisdiction of | (Commission | (I.R.S.<br> Employer |
| Incorporation) | File<br> Number) | Identification<br> No.) |
1550W Horizon Ridge Pkwy, Ste R #3040, Henderson, NV 89012
(Address of Principal Executive Offices)
(984)261-7338
(Registrant’s Telephone Number, including area code)
201S. Elliott Road, Suite 538, Chapel Hill, North Carolina 27514
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see general instruction A.2. below):
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14-a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
| Title of each class | Trading Symbols(s) | Name of each exchange on which registered |
|---|---|---|
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
|---|
On May 29, 2024, Judith S. Miller was terminated as Interim Chief Financial Officer and Chief Business Officer of the Company.
| Item 9.01 | Financial Statements and Exhibits. |
|---|
(d) Exhibits.
| Exhibit No. | Description of Exhibit |
|---|---|
| 104 | Cover<br> Page Interactive Data File (embedded within Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 31, 2024
| GENVOR INCORPORATED | |
|---|---|
| By: | /s/ Chad Pawlak |
| Name: | Chad<br> Pawlak |
| Title: | Chief<br> Executive Officer |